Antibodies to tumor endothelial marker 8

The present invention is directed to particular antibodies and fragments thereof that find use in the detection, prevention and treatment of diseases and disorders associated with abnormal angiogenesis. In particular, these antibodies detect tumor endothelial marker 8 (TEM8) in its native and cell-s...

Full description

Saved in:
Bibliographic Details
Main Authors SU YUNPENG, LEPPLA STEPHEN H, FRANKEL ARTHUR E, ST. CROIX BRAD
Format Patent
LanguageEnglish
Published 12.04.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention is directed to particular antibodies and fragments thereof that find use in the detection, prevention and treatment of diseases and disorders associated with abnormal angiogenesis. In particular, these antibodies detect tumor endothelial marker 8 (TEM8) in its native and cell-surface expressed form. Also disclosed are improved methods for producing monoclonal antibodies, as well as pharmaceutical compositions and kits.
Bibliography:Application Number: US201113884899